TNF-α is a novel target of miR-19a

International Journal of Oncology

Volumn 38, Issue 4, 2011, Pages 1013-1022

  Liu, Mei ^a   Wang, Zaozao ^a   Yang, Shangbin ^a,b   Zhang, Wei ^a   He, Shun ^a   Hu, Chenfei ^a   Zhu, Hongxia ^a   Quan, Lanping ^a   Bai, Jinfeng ^a   Xu, Ningzhi ^a  

^a CANCER HOSPITAL   (China)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Esophageal squamous cell carcinoma; miR 17 92 cluster; miR 19a; Tumor necrosis factor

Indexed keywords

ANTAGOMER 19A; ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; MICRORNA; MIR 17 5P; MIR 17 92; MIR 18A; MIR 19A; MIR 20A; MIR 92 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTISENSE THERAPY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE CLUSTER; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952322000     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.924     Document Type: Article

References (31)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
3. McManus MT: MicroRNAs and cancer. Semin Cancer Biol 13: 253-258, 2003.
4. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005. (Pubitemid 40839734)
5. Hayashita Y, Osada H, Tatematsu Y, et al: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005. (Pubitemid 41541436)
6. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005. (Pubitemid 40094598)
7. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003. (Pubitemid 38058492)
8. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105, 2007. (Pubitemid 46991392)
9. Hossain A, Kuo MT and Saunders GF: Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26: 8191-8201, 2006. (Pubitemid 44631015)
10. Dews M, Homayouni A, Yu D, et al: Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065, 2006. (Pubitemid 44325933)
11. Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179, 2005.
12. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
13. Gleave ME and Monia BP: Antisense therapy for cancer. Nat Rev Cancer 5: 468-479, 2005. (Pubitemid 40791489)
14. Matsubara H, Takeuchi T, Nishikawa E, et al: Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26: 6099-6105, 2007. (Pubitemid 47373805)
15. Zhou C, Liu S, Zhou X, et al: Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer 113: 891-898, 2005. (Pubitemid 40096868)
16. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G and Murcia JM: Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273: 33533-33539, 1998. (Pubitemid 29005737)
17. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144, 2006.
18. Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med 349: 2241-2252, 2003. (Pubitemid 37485141)
19. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
20. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005. (Pubitemid 40839736)
21. Fontana L, Fiori ME, Albini S, et al: Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 3: e2236, 2008.
22. Mandard AM, Hainaut P and Hollstein M: Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 462: 335-342, 2000. (Pubitemid 30190239)
23. Mineno J, Okamoto S, Ando T, et al: The expression profile of microRNAs in mouse embryos. Nucleic Acids Res 34: 1765-1771, 2006.
24. Krek A, Grun D, Poy MN, et al: Combinatorial microRNA target predictions. Nat Genet 37: 495-500, 2005. (Pubitemid 40617277)
25. Oka M, Hirose K, Iizuka N, et al: Cytokine mRNA expression patterns in human esophageal cancer cell lines. J Interferon Cytokine Res 15: 1005-1009, 1995.
26. Rasmussen H, Rasmussen C, Lempicki M, et al: TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene. Cancer Gene Ther 9: 951-957, 2002. (Pubitemid 35278568)
27. Perez C, Albert I, DeFay K, Zachariades N, Gooding L and Kriegler M: A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63: 251-258, 1990.
28. Kriegler M, Perez C, DeFay K, Albert I and Lu SD: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53: 45-53, 1988.
29. Vilcek J and Lee TH: Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266: 7313-7316, 1991. (Pubitemid 21906368)
30. Olive V, Bennett MJ, Walker JC, et al: miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23: 2839-2849, 2009.
31. Krutzfeldt J, Rajewsky N, Braich R, et al: Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689, 2005.